Nuvation Bio NUVB Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's unrealized gains on investments?
- Nuvation Bio (NUVB) reported unrealized gains on investments of $797K in Q4 2025.
- How has Nuvation Bio's unrealized gains on investments changed year-over-year?
- Nuvation Bio's unrealized gains on investments increased by 33.7% year-over-year, from $596K to $797K.
- What is the long-term trend for Nuvation Bio's unrealized gains on investments?
- Over 5 years (2020 to 2025), Nuvation Bio's unrealized gains on investments has grown at a -12.5% compound annual growth rate (CAGR), from $1.56M to $797K.
- What does unrealized gains on investments mean?
- This reflects the cumulative increase in the fair value of investment securities held by the company that have not yet been sold. It serves as an indicator of the performance of the company's treasury or investment management strategy.